type here...

CATEGORIES

Healthcare

LATEST

1...202122...74Page 21 of 74

TRENDING

EDITORS CHOICE

Twitter’s Decision to Stand-down on COVID Misinformation Highlights a New Symptom — “Trust Deregulation”

Gil Bashe, Medika Life Editor -
If Twitter and Elon Musk Fail and Fall, Who Will Celebrate? Twitter and COVID misinformation monitoring.

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Book Review. Making the Digital Health Revolution

Medika Life -
Law and the legal profession has a very distinct impact on the development and future of the digital health revolution. Making the Health Revolution addresses

Looking for Zebras: Medical Mysteries and Transformational Patient Moments

Gil Bashe, Medika Life Editor -
While medicine has become more advanced and specialized, it has also become increasingly fragmented. For people is hard-to-diagnose conditions, that's another obstacle to care.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories